Read more

April 28, 2022
1 min read
Save

Long-term IOP, disc hemorrhage risk factors for visual field progression

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Long-term IOP fluctuations and disc hemorrhage increased the risk for visual field loss in patients with advanced primary open-angle glaucoma, according to a study published in the Journal of Glaucoma.

Perspective from Derek MacDonald, OD, FAAO

“Patients at an advanced stage of the disease with severe loss of visual field are especially at risk of serious disability,” Jihei Sara Lee, MD, of Yonsei University College of Medicine in South Korea, and colleagues wrote. “Studies on advanced glaucoma, however, are relatively few, because not only is advanced glaucoma a challenging topic, it also lacks a clear definition. ... However, considering the devastating consequences of serious visual field loss, advanced glaucoma merits detailed investigations.”

To better understand risk predictors for progression of visual field, Lee and colleagues conducted a retrospective review of medical records to enroll 122 patients with advanced primary open-angle glaucoma, all of whom underwent IOP measurement, standard automated perimetry, Cirrus OCT (Zeiss) and fundus photography at 6-month intervals.

Thirty-six patients (mean age, 51.9 years; 56.8% men) had VF progression and showed greater long-term IOP fluctuations vs. the no progression group (2.6 mm Hg vs. 2 mm Hg; P = .008). Researchers also detected disc hemorrhage more frequently in the progression group (40.5% vs. 17.4%; P = .005).

Although long-term IOP fluctuations and disc hemorrhage were independent risk factors for visual field progression, patients with both conditions were at greater risks for progression (P = .035).

“Patients with advanced nerve damage and field loss, especially those in whom these factors are recognized, need vigorous treatment and close monitoring,” Lee and colleagues concluded.